CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME UPDATE IN DIAGNOSIS.

Slides:



Advertisements
Similar presentations
Antiphospholipid symdrome “APS”
Advertisements

Grand Round Dr Amir H Mani Fellow NUH. History 27 years Indian, F C/o Progressive BOV for 1/12 RE(27 /08/05) Had RE photophobia and pain month back Similar.
Heather D. Mannuel, MD, MBA March 12, 2008
1 IN THE NAME OF GOD. 2 SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)
1 THROMBOPHILIA. 2 Thrombophilia is technical term for hypercoagulable state Thrombosis (arterial or venous) is produced by a shift in the balance between.
1 Classification criteria for APS Clinical Criteria (Sydney 2004) Myakis et al. J Thromb Haemost 2006;4: Vascular thrombosis one or more clinical.
1 DVT/ PE Dr Faiza. A. Qari DVT Mortality/Morbidity: Death from DVT is attributed to massive pulmonary embolism Sex: The male-to-female ratio.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
Morning Report January 19 th, 2010 Jason Kidd.
Renal Artery Thrombosis May 5, Outline Etiology Clinical Manifestations Differential Diagnosis Diagnosis Treatment Prognosis.
Mechanism and New. Lupus Erythematosus - Medication NSAIDs may be used for musculoskeletal and mild systemic complaints, although ibuprofen.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
Anti-phospholipid syndrome Clinton Mitchell 5th year Haematology.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Antiphospholipid antibody syndrome due to interferon  treatment for hepatitis C Michi Shinohara, MD Pacific Dermatologic Association August 10, 2008.
Oct. 14 There is no evidence of bowel obstruction or dilatation. 1. Extensive axillary, mediastinal, abdominal, pelvic lymphadenopathy, as above, most.
Drugs used in coagulation disorders By S.Bohlooli, Ph.D.
WEGENER’S GRANULOMATOSIS
Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.
Total Joint Replacement
Pleural diseases: Case Studies
Disseminated intravascular coagulation
Antiphospholipid Syndrome
To Clot Or Not To Clot… Emergency Care for Coagulation Disorders/Conditions Rebecca Goldsmith Pediatric Thrombosis/Hemophilia Nurse McMaster Children’s.
DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.
Tuesday Conference Approach to Thrombocytopenia Selim Krim, MD Assistant Professor TTUHSC.
CARDIOVASCULAR MODULE: DEEP VENOUS THROMBOSIS THROMBOPHLEBITIS Adult Medical-Surgical Nursing.
Antiphospholipid Syndrome. The antiphospholipid syndrome is an autoimmune disease that is characterized clinically by vascular thrombosis and pregnancy.
COMPLICATIONS of PPH. Hypovolemic shock and organ failure: renal failure, stroke, myocardial infarction, postpartum hypopituitarism(sheehan syndrome)
Hypercoagulable States. Acquired versus inherited Acquired versus inherited “Provoked” vs idiopathic VTE “Provoked” vs idiopathic VTE Who should be tested.
ANTIPHOSPHOLIPID SYNDROME (APS) and Pregnancy
Thrombophilia. Definition –Tendency to develop clots due to predisposing factors that may be genetically determined.
Hemodynamics, Thromboembolism and Shock Review with Animations Nicole L. Draper, MD.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. MYOCARDIAL INFARCTION Prof.
Respiratory CONNECT meeting Dr Julius Cairn. Risk stratification in PE Clinical parameters – shock, JVP, S3 Imaging – CTPA, echo Biomarkers – Troponin,
Pulmonary Embolism Pulmonary embolism is blockage in one or more arteries in your lungs. Maggie Trainor.
ANTIPHOSPHOLIPID SYNDROME (APS) and Pregnancy
Case Discussion Dr. Raid Jastania. A 65-year-old man presented to the emergency room with a recent (4-hour) history of severe chest pain radiating to.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Comparative Effectiveness of Hospital Outcomes in Medicare Inpatient Elective Laparoscopic Cholecystectomy (ELC)  Data source: Medicare Limited Data Set.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Low risk: young, with minor illnesses, who are to undergo operations lasting 30 min or less. Moderate risk: over 40 or with a debilitating illness who.
ANTIPHOSPHOLIPID SYNDROME CLINICAL MANIFESTATIONS.
Guidelines on the investigation and management of the APL syndrome Dr Wan Zaidah Abdullah BJH : (Revised of !991 guidelines by the Haemostasis.
Postpartum period in women with systemic lupus erythematosus BY DR KH ELMIZADEH.
Henoch-Scholein Purpura. Introduction Systemic vasculitis with a prominent cutaneous component. Systemic vasculitis with a prominent cutaneous component.
Course Lecturer: Imon Rahman
Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according.
Nephrotic syndrome & Thromboembolic complications 신장내과 R3 김진숙 / Prof. 임천규 R3 김진숙 / Prof. 임천규.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
The antiphospholipid syndrome (APS) is defined by two major components (see 'Classification criteria' below: 'Classification criteria' The occurrence.
Autoimmune Disorders During Pregnancy -Lupus -Antiphospholipid syndrome Rovnat Babazade, MD Obstetrical Anesthesia-2016.
Warfarin in primary care
Pregnancy in women with antiphospholipid syndrome
EVALUATION OF THROMBOTIC RISK IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE 153 R. Demetrio Pablo1, P.
Antiphospholipid Antibody Syndrome
Cholesterol crystal embolism
Hemolytic uremic syndrome
Antiphospholipid Syndrome
Autoimmune disease in pregnancy
ACUTE ARTERIAL OCCLUSION (Acute Limb Ischemia )
How I treat the antiphospholipid syndrome
Disseminated intravascular coagulation (DIC) + Thrombotic microangiopathies (TTP+HUS) Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University.
IMMUNE THROMBOCYTOPENIC PURPURA MBBSPPT.COM
Thrombolysis therapy for Pulmonary Embolism
Acute Pancreatitis (1) C.L.I.P.S.
Target population/question
Presentation transcript:

CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME UPDATE IN DIAGNOSIS

THE "CAPS" REGISTRY International Registry of Patients with Catastrophic APS

CATASTROPHIC APS: Presenting Manifestations (I) CARDIOPULMONARY INVOLVEMENT 25% Acute respiratory failure/dyspnea 13% Chest pain 5% Pulmonary embolism 4% Cardiac failure 3% Myocardial infarction 1% CNS INVOLVEMENT 22% ABDOMINAL PAIN 22% RENAL INVOLVEMENT 14% Renal failure 13% Hematuria 1% CAPS Registry, 2005

CATASTROPHIC APS: Presenting Manifestations (II) CUTANEOUS INVOLVEMENT 9% Digital necrosis/gangrene 5% Ulcers 3% Purpura 1% FEVER 10% OTHER MANIFESTATIONS Leg pain 4% Arterial thrombosis 1% Multiple organ thrombosis 1% Adrenal failure 1% CAPS Registry, 2005

CATASTROPHIC APS Frequency of System Involvement (I) INTRAABDOMINAL 83% Renal 72% Hepatic 37% Splenic 17% Gastrointestinal 14% Pancreatic 11% Adrenal 10% CAPS Registry, 2005

CATASTROPHIC APS Frequency of System Involvement (II) PULMONARY 64% CEREBROVASCULAR 61% CARDIAC 55% CUTANEOUS 52% OTHER Venous thrombosis 27% Peripheral arterial thromb. 11% Bone marrow necrosis 10% CAPS Registry, 2005

CATASTROPHIC APS International consensus for classification criteria 1. Clinical evidence of vessel occlusions affecting 3 or more organs or systems. 2. Development of the manifestations simultaneously or in less than a week. 3. Confirmation by histopathology of small vessel occlusion in at least one organ. 4. Serological confirmation of the presence of aPL (LA and/or aCL). -Definite catastrophic APS: All 4 criteria. -Probable catastrophic APS: -1, 2 & 4 -1, 3 & 4 and the development of the third event in more than a week but less than a month, despite anticoagulation

ANALYSIS OF THE INTERNATIONAL CONSENSUS STATEMENT ON PRELIMINARY CLASSIFICATION CRITERIA FOR CAPS USING THE “CAPS REGISTRY” Cervera R and Asherson RA, for the “CAPS Registry Project Group”. “Definite” CAPS: 72/147 (49%) “Probable” CAPS: 60/147 (41%) Sensitivity: 89% Specificity: 100%. EULAR Prize-2003

CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME UPDATE IN TREATMENT

CATASTROPHIC APS Treatment (I) Anticoagulation (IV Heparin followed by coumadin) 84% Steroids (high dose IV) 80% Cyclophosphamide 35% Plasma exchange 20% IV Gammaglobulin 19% CAPS Registry, 2005

CATASTROPHIC APS Treatment (II) Hemodialysis 6% Fibrinolytics 6% Prostacyclin 5% Azathioprine 1% Danazol 1% Splenectomy 1% Cyclosporine 1% CAPS Registry, 2005

CATASTROPHIC APS Outcome (I) DEATH 50% SLE 67% Primary APS 46% Hemolytic anemia 62% Microangiopathic anemia 57% Thrombocytopenia 47% DIC 43% CAPS Registry, 2005

CATASTROPHIC APS Outcome (II) RECOVERY 50% Plasma exchange 65% Anticoagulants 63% Steroids 54% IV Gammaglobulins 50% Cyclophosphamide 41% AC+St+Pl/IV-GG 70% AC+St+Pl/IV-GG+Cyclo 50% (p=0.02) CAPS Registry, 2005

CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME UPDATE IN PATHOGENESIS

CATASTROPHIC APS: Precipitating Factors (I) INFECTIONS 35% Respiratory tract 15% Cutaneous 8% Urinary tract 6% Sepsis 3% Gastrointestinal 1% Other 9% CAPS Registry, 2005

CATASTROPHIC APS: Precipitating Factors (II) SURGERY, TRAUMA & INVASIVE PROCEDURES 13% NEOPLASIA 8% ANTICOAGULATION WITHDRAWAL /LOW INR 8% OBSTETRIC COMPLICATIONS6% SLE FLARES 5% ORAL CONTRACEPTIVES 3% NO FACTOR IDENTIFIED 35% CAPS Registry, 2005

CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME ? Therapeutic Vaccines